Search Within

Shanu Modi

  1. "Elsevier Inc."
Formats
  1. Journal Article (9)
  2. Meeting Abstract (8)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Breast Medicine Service (19)
  2. Department of Medicine (19)
  3. Solid Tumor Oncology Division (19)
  4. Biostatistics Service (9)
  5. Epidemiology and Biostatistics (9)
  6. Survivorship Research (9)

More Groups

People
  1. Andrew Seidman (7)
  2. Clifford Hudis (7)
  3. Gabriella D'Andrea-Carlino (5)
  4. Larry Norton (5)
  5. Sujata Patil (5)
  6. Chau Dang (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (2)
  4. 2021 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Clinical Breast Cancer (8)
  2. Breast (2)
  3. Cancer Treatment Reviews (2)
  4. European Journal of Cancer (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Advances in Pharmacology (1)

More Publications

Publishers
  1. Elsevier Inc. (19)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors
    Meeting Abstract

    Juric, D.; Rodon, J.; Bauer, T. M.; Wainberg, Z.; Tolaney, S.; Modi, S.; Martin, A. G.; Hengelage, T.; Melendez, M.; Choudhury, S.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Triple blockade with LEE011, everolimus, and exemestane in women with ER+/HER2-advanced/metastatic breast cancer: Results from a Phase Ib clinical trial
    Meeting Abstract

    Bardia, A.; Chavez-MacGregor, C.; Modi, S.; Campone, M.; Ma, B.; Kittaneh, M.; Dirix, L.; Motta, M.; Zhang, V.; Bhansali, S.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with Metastatic breast cancer
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Lake, D.; Gilewski, T.; Robson, M.; Goldfarb, S.; Drullinsky, P.; Sugarman, S.; Wasserheit Leiblich, C.; Fasano, J.; more...
    Clinical Breast Cancer (2014)

    Fulltext@MSK | Save
  • HSP90 inhibitors for cancer therapy and overcoming drug resistance
    Journal Article

    Jhaveri, K.; Modi, S.
    Advances in Pharmacology (2012)

    Fulltext@MSK | Save
  • Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results
    Journal Article

    Morris, P. G.; Van Poznak, C.; Modi, S.; Mak, A. F.; Patil, S.; Larson, S.; Hudis, C. A.; Divgi, C.; Grewal, R. K.
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Bone scan imaging before and after intravenous bisphosphonate therapy for osseous metastases from breast cancer
    Meeting Abstract

    Van Poznak, C.; Grewal, R.; Morris, P.; Modi, S.
    Cancer Treatment Reviews (2008)

    Fulltext@MSK | Save
  • A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
    Journal Article

    Modi, S.; D'Andrea, G.; Norton, L.; Yao, T. J.; Caravelli, J.; Rosen, P. P.; Hudis, C.; Seidman, A. D.
    Clinical Breast Cancer (2006)

    Fulltext@MSK | Save
  • A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane
    Journal Article

    Modi, S.; Currie, V. E.; Seidman, A. D.; Bach, A. M.; Panageas, K. S.; Theodoulou, M.; Moasser, M. M.; D'Andrea, G. M.; Lake, D. E.; Choi, J.; more...
    Clinical Breast Cancer (2005)

    Fulltext@MSK | Save
  • Single-agent gemcitabine in the treatment of advanced breast cancer
    Journal Article

    Modi, S.; Seidman, A. D.
    Clinical Breast Cancer (2004)

    Fulltext@MSK | Save